ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 2,825.00
-190.00 (-6.30%)
At close: Jul 20, 2026
ImmuneOncia Therapeutics Market Cap
ImmuneOncia Therapeutics has a market cap or net worth of 257.84 billion as of July 20, 2026. Its market cap has decreased by -44.62% in one year.
Market Cap
257.84B
Enterprise Value
238.91B
Revenue
59.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,825.00
ChartMarket Cap Chart
Since May 19, 2025, ImmuneOncia Therapeutics's market cap has decreased from 547.53B to 257.84B, a decrease of -52.91%. That is a compound annual growth rate of -47.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 257.84B | -73.30% |
| Dec 30, 2025 | 965.63B | 76.36% |
| May 19, 2025 | 547.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 481.47B |
| HEM Pharma | 287.41B |
| NOVAREX | 231.71B |
| DAE HWA Pharmaceutical | 174.99B |
| CellBion | 170.48B |
| Cosmax Nbt | 162.79B |
| GC WellBeing | 145.27B |
| Vivozon Pharmaceutical | 143.49B |